Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Prausnitz

Showing results (281-290 of 290) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 290 results.
Clinical and Vaccine Immunology : CVI|July 16, 2010
Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in miceJae-Min Song, Yeu-Chun Kim, Aleksandr S Lipatov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Extended delivery of vaccines to the skin improves immune responsesJessica C Joyce, Hila E Sella, Heather Jost, et al.
Lancet (London, England)|July 2, 2017
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trialNadine G Rouphael, Michele Paine, Regina Mosley, et al.
NPJ Vaccines|July 15, 2021
Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trialNadine G Rouphael, Lilin Lai, Sonia Tandon, et al.
Lancet (London, England)|May 2, 2024
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trialIkechukwu Adigweme, Mohammed Yisa, Michael Ooko, et al.
Translational Vision Science & Technology|May 10, 2022
Evaluation of Spatially Targeted Scleral Stiffening on Neuroprotection in a Rat Model of GlaucomaBrandon G Gerberich, Bailey G Hannon, Dillon M Brown, et al.
Journal of Diabetes Science and Technology|October 4, 2021
Continuous Ketone Monitoring Consensus Report 2021Kevin T Nguyen, Nicole Y Xu, Jennifer Y Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2024
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skinMaria Dul, Mohammed Alali, Mahmoud Ameri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2023
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) productMaria Dul, Mohammed Alali, Mahmoud Ameri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 7, 2026
Microneedle array platforms for drug delivery and biomarker sensing: From skin mechanics guided design to scalable manufacture for clinical utilityJiachi Zhou, Lei Wu, Minna Wyttenbach, et al.
Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Clinical and Vaccine Immunology : CVI|July 16, 2010
Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in miceJae-Min Song, Yeu-Chun Kim, Aleksandr S Lipatov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Extended delivery of vaccines to the skin improves immune responsesJessica C Joyce, Hila E Sella, Heather Jost, et al.
Lancet (London, England)|July 2, 2017
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trialNadine G Rouphael, Michele Paine, Regina Mosley, et al.
NPJ Vaccines|July 15, 2021
Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trialNadine G Rouphael, Lilin Lai, Sonia Tandon, et al.
Lancet (London, England)|May 2, 2024
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trialIkechukwu Adigweme, Mohammed Yisa, Michael Ooko, et al.
Translational Vision Science & Technology|May 10, 2022
Evaluation of Spatially Targeted Scleral Stiffening on Neuroprotection in a Rat Model of GlaucomaBrandon G Gerberich, Bailey G Hannon, Dillon M Brown, et al.
Journal of Diabetes Science and Technology|October 4, 2021
Continuous Ketone Monitoring Consensus Report 2021Kevin T Nguyen, Nicole Y Xu, Jennifer Y Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2024
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skinMaria Dul, Mohammed Alali, Mahmoud Ameri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2023
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) productMaria Dul, Mohammed Alali, Mahmoud Ameri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 7, 2026
Microneedle array platforms for drug delivery and biomarker sensing: From skin mechanics guided design to scalable manufacture for clinical utilityJiachi Zhou, Lei Wu, Minna Wyttenbach, et al.
Pageof 29